Module for acquiring electroencephalograph signals from a patient

• US 6,430,437 B1
• Filed: 10/27/2000
• Issued: 08/06/2002
• Est. Priority Date: 10/27/1999
• Status: Expired due to Term

• Current Assignee: SEDLine, Inc. (Masimo Corporation)
• Original Assignee: Physiometrix, Inc. (Pfizer Inc.)
• Inventors: Marro, Dominic P.
• Primary Examiner(s): Shaver, Kevin
• Assistant Examiner(s): WINGOOD, PAMELA LYNN
• Application Number:
  US09/699,123
• Time in Patent Office: 648 Days
• Field of Search: 600/544
• US Class Current: 600/544
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/30 Input circuits therefor
• CPC Class Codes: A61B 5/369 Electroencephalography [EEG] devices for psychotechnics A61B5/16

Abstract

A patient module comprising an 8 channel EEG pre-amplifier whose signal acquisition and processing characteristics are optimized for use in the operating room and intensive care unit. This patient module comprises at least an optimized multistage input filter, an optimized input stage circuit topography, ultra-isolation, oversampling, a multiplexer inter-sample charge dump, and high performance low-frequency-enhanced shielding.

Claims

1. A patient module for acquisition of EEG signals in a harsh electromagnetic and electrostatic environment comprising:

a. a plurality of high resistance opto-isolators;

b. at least one pre-amplifier structured to suppress EMI to eliminate electrical artifacts;

c. at least two optimized multistage input filters;

d. an optimized input stage circuit topography;

e. an ultra-isolation sub-module;

f. an oversampling sub-module;

g. a multiplexer inter-sample charge dump; and

h. a high-performance low frequency enhanced shielding system configured to shield electronically the amplifier from electromagnetic and electrostatic fields, thereby reducing the artifact of the EEG signal.

2. The patient module of claim 1 in which the at least two optimized multistage input filters comprise a signal filter and a reference filter.

3. The patient module of claim 2 in which the signal filter and the reference filter each comprise an active element and a passive element.

4. The patient module of claim 3 in which the passive filter element for each of the signal filter and the reference filter comprise a resistance element, a capacitance element, and an inductance element optimized for 90 Hz signal bandwidth with isolation and suppression of frequencies between 0.5 MHz and 2 MHz.

5. The patient module of claim 4 in which the inductance element for each of the signal filter and the reference filter comprise separate windings on a common mode choke.

6. The patient module of claim 5 in which the common mode choke is wound on a toroidal core.

7. The patient module of claim 4 in which the passive filter element for each of the signal filter and the reference filter additionally comprises a device that bypasses RF energy.

8. The patient module of claim 7 in which the device that bypasses RF energy is a Transorb.

9. The patient module of claim 4 in which the passive filter element for each of the signal filter and the reference filter additionally comprises an anti-aliasing filter.

10. The patient module of claim 1 in which the multiplexer inter-sample charge dump comprises a low charge injection multiplexer coupled to an analog switch.

11. The patient module of claim 1 in which the high-performance low frequency enhanced shielding system comprises an EMC barrier and a dielectric barrier.

12. The patient module of claim 1 in which the optimized input stage circuit topography comprises multi-layer printed circuit boards with minimized input circuitry.

13. The patient module of claim 1 additionally comprising a medical grade isolated power supply.